2011 Annual Meeting | BRAINS Colloquium: Surfing Through the Business of Neurology

Date Saturday 04/09/11

Time 12:00 PM - 04:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Colloquium

Director(s) Bryan Soronson, CRA, FACMPE, MPA

Topic(s)

Learning Objectives Participants should be familiar with key provisions of health care reform that will have a direct impact on their neurology practice and what actions they need to take to as a result; how to determine if participating in clinical trials is the right choice for their practice and determining the appropriate budgets for such trials; and what steps they need to take now to prepare for the implementation of ICD-10-CM.

CME Available No CME available

Core Competencies Professionalism

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Didactic, Audience Participation

Event Timeline
12:00 PM - 12:15 PM		Program and Faculty Introduction Bryan Soronson, CRA, FACMPE, MPA
12:15 PM - 01:15 PM		Government's Impact on the Practice of Neurology David A. Evans, MBA
01:15 PM - 02:15 PM		Participating in Clinical Trials–A Double-Edged Sword Bryan Soronson, CRA, FACMPE, MPA
02:15 PM - 02:30 PM		Break
02:30 PM - 03:30 PM		Update on ICD-10-CM Content and Implementation Jeffrey R. Buchhalter, MD, FAAN
03:30 PM - 04:00 PM		Emerging Issues/Question and Answer Session

Faculty Disclosures
Jeffrey R. Buchhalter, MD, FAAN	Dr. Buchhalter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Foundation. Dr. Buchhalter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epilepsy Study Consortium. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Buchhalter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex.
Bryan Soronson, CRA, FACMPE, MPA	Mr. Soronson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Texas Neurology.
David A. Evans, MBA	Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon Therapeutics/Amgen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Averitas . Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Mr. Evans has stock in NeuroNet GPO. Mr. Evans has stock in NeuroNet Pro. Mr. Evans has stock in NeuroDiscovery.AI.

��ɫ��

��ɫ��